Cross species application of quantitative neuropathology assays developed for clinical Alzheimer’s disease samples

A major obstacle for preclinical testing of Alzheimer’s disease (AD) therapies is the availability of translationally relevant AD models. Critical for the validation of such models is the application of the same approaches and techniques used for the neuropathological characterization of AD. Deposit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pathobiol Aging Age Relat Dis
Autors principals: Urfer, Silvan R., Latimer, Caitlin S., Ladiges, Warren, Keene, C. Dirk, Benbow, Sarah, Harrison, Benjamin, Promislow, Daniel E.L., Kaeberlein, Matt, Kraemer, Brian C, Wang, Adrienne, Guscetti, Franco, Darvas, Martin
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2019
Matèries:
Technical Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735310/
https://ncbi.nlm.nih.gov/pubmed/31528297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20010001.2019.1657768
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars